We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
바이오제약 기업 Biofrontera Inc.는 미국에서 피부과 질환 치료용 의약품을 상업화하고 있습니다. 이 회사는 전암성 피부 병변인 광선 각화증 치료에 사용되는 Ameluz, BF-RhodoLED, RhodoLED XL lamp series, RhodoLED Lamps를 제공합니다. 이 회사는 2015년에 설립되었으며, 매사추세츠주 워번에 본사를 두고 있습니다.